Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Clinical trial NCT04492956 · COMPLETED

Trial details

NCT number: NCT04492956
Sponsor: Emalex Biosciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood-Onset Fluency Disorder (Stuttering)

Start date: 2020-10-02
Primary completion: 2022-03-07
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.